<?xml version='1.0' encoding='us-ascii'?>
<TimeML xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:noNamespaceSchemaLocation="http://timeml.org/timeMLdocs/TimeML_1.2.1.xsd">
<DOCID>24</DOCID>
<TEXT>
Exhibit . COLLABORATION AGREEMENT THIS COLLABORATION AGREEMENT (the "Agreement") is <EVENT class="COREFERENCE" eid="e0">entered</EVENT> into as of November , (the "Effective Date ") by and between BIOCEPT, INC., a California corporation having an address of Nancy Ridge Drive, Suite , San Diego, CA ("Biocept"), and LIFE TECHNOLOGIES CORPORATION, a Delaware corporation having an address of Van Allen Way, Carlsbad, California ("Life Technologies"). WHEREAS, Life Technologies, through its Medical Sciences Division, is <EVENT class="COREFERENCE" eid="e1">engaged</EVENT> in the <EVENT class="COREFERENCE" eid="e2">development</EVENT> and <EVENT class="COREFERENCE" eid="e3">commercialization</EVENT> of diagnostic systems, tests and laboratory services, including in oncology; WHEREAS, Biocept has <EVENT class="COREFERENCE" eid="e4">developed</EVENT> expertise and proprietary technology in <EVENT class="COREFERENCE" eid="e5">enrichment</EVENT> <EVENT class="COREFERENCE" eid="e6">extraction</EVENT> and <EVENT class="COREFERENCE" eid="e7">analysis</EVENT> of circulating tumor cells (CTCs) for use in laboratory <EVENT class="COREFERENCE" eid="e8">developed</EVENT> tests <EVENT class="COREFERENCE" eid="e9">used</EVENT> for the non-invasive and early stage <EVENT class="COREFERENCE" eid="e10">detection</EVENT> and <EVENT class="COREFERENCE" eid="e11">characterization</EVENT> of primary, metastatic or recurrent cancers; and WHEREAS, Life Technologies and Biocept desire to <EVENT class="COREFERENCE" eid="e12">collaborate</EVENT> so that Biocept will <EVENT class="COREFERENCE" eid="e13">develop</EVENT> and <EVENT class="COREFERENCE" eid="e14">commercialize</EVENT> one or more Tests, as <EVENT class="COREFERENCE" eid="e15">defined</EVENT> herein, for Non-Small Cell Lung Cancer (NSCLC), using their respective technologies and expertise, on the terms and subject to the conditions set forth herein. Life Technologies and Biocept will both <EVENT class="COREFERENCE" eid="e16">promote</EVENT> the test and <EVENT class="COREFERENCE" eid="e17">perform</EVENT> different components of the test, and Life Technologies will <EVENT class="COREFERENCE" eid="e18">provide</EVENT> test results in the form of <EVENT class="COREFERENCE" eid="e19">reports</EVENT> to physicians. NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants <EVENT class="COREFERENCE" eid="e20">contained</EVENT> herein, and intending to be legally <EVENT class="COREFERENCE" eid="e21">bound</EVENT> , the parties hereby <EVENT class="COREFERENCE" eid="e22">agree</EVENT> as follows : . DEFINITIONS . "Affiliate" shall mean any company or entity controlled by, controlling, or under common control with a party hereto and shall include any company more than % of whose voting stock or participating profit interest is owned or controlled, directly or indirectly, by a party, and any company which owns or controls, directly or indirectly, more than % of the voting stock of a party. . "Assay" shall mean Biocept's OncoCEE-LUâ¢ (and OncoCEE-LUâ¢ with Mutation Analysis) laboratory developed assay for <EVENT class="COREFERENCE" eid="e23">characterization</EVENT> and <EVENT class="COREFERENCE" eid="e24">profiling</EVENT> of CTCs from NSCLC patients, which shall incorporate, as <EVENT class="COREFERENCE" eid="e25">Phase</EVENT> , CTC <EVENT class="COREFERENCE" eid="e26">enumeration</EVENT> by cytokeratin and CD (and CEE-Enhancedâ¢ when available), EML /Alk <EVENT class="COREFERENCE" eid="e27">fusions</EVENT> and EGFR <EVENT class="COREFERENCE" eid="e28">amplification</EVENT> by fluorescence in situ <EVENT class="COREFERENCE" eid="e29">hybridization</EVENT> (determined by Biocept); and as <EVENT class="COREFERENCE" eid="e30">Phase</EVENT> , the additional <EVENT class="COREFERENCE" eid="e31">detection</EVENT> of mutations for relevant genes, e.g., K-RAS, EGFR and B-RAF, as agreed by the parties, on captured CTCs and/or cell-free circulating DNA, as agreed by the parties, and employing technologies that potentially may include Biocept's Selector technology, and any <EVENT class="COREFERENCE" eid="e32">improvements</EVENT> or <EVENT class="COREFERENCE" eid="e33">enhancements</EVENT> thereto, exclusive of new analytes (which are discussed in Section . (f) under Collaboration Assays) or applications to primary screening. . "Biocept Trademarks" shall mean Biocept, Inc., "OncoCEE-LU ", "OncoCEEâ¢", "CEE-Sure ", CEE- Enhancedâ¢", and/or such other trademarks and trade names owned or licensed, and used, by Biocept and/or its Affiliates in the Territory to identify the Tests, in each case, whether or not registered. . "Life Technologies Trademarks," shall mean Life Technologies , Life Technologies Medical Sciences and/or such other trademarks and trade names owned or licensed and used by Life Technologies to identify the Tests, in each case, whether or not registered. . "CLIA" shall mean the Clinical Laboratory Improvement Amendments of , as it may be amended from time to time. . "Collaboration" shall have the meaning provided Section . . . "Collaboration Assay(s)" shall have the meaning provided in Section . (e). . "CPT Code" shall mean the American Medical Association's ("AMA") " Current Procedural Terminology" as published in the AMA's CPT Process Manual, Fourth Edition and any such future editions, for procedures used in <EVENT class="COREFERENCE" eid="e34">performance</EVENT> of the Assay, and amounts reimbursed by Medicare for such procedures for location , as <EVENT class="COREFERENCE" eid="e35">modified</EVENT> annually . . "Designated Executive Officer" shall mean the executive officers of each party designated in writing be each party as being responsible for resolving <EVENT class="COREFERENCE" eid="e36">disputes</EVENT> related to the Collaboration, which shall initially be David Hale on behalf of Biocept and Ronnie Andrews on behalf of Life Technologies. . "FDA" shall mean the United States Food and Drug Administration, or any successor federal agency thereto. . "HIPAA" shall mean, collectively, the Health Insurance Portability and Accountability Act of , as amended, and all regulations promulgated thereunder at C.F.R. parts through , and the Health Information Technology for Economic and Clinical Health Act of and related regulations and guidelines. . "Intellectual Property Rights" means all now or hereafter existing patents, patent applications, copyrights, trademarks (including service marks), trade secrets, know-how, mask work rights and design rights, whether registered or unregistered, and all rights or forms of protection of a similar nature having equivalent or similar effect to any of the foregoing, which may subsist anywhere in the world. . "<EVENT class="COREFERENCE" eid="e37">Launch</EVENT> shall mean formal commercial availability and <EVENT class="COREFERENCE" eid="e38">offering</EVENT> to physicians of a Test, as mutually agreed upon by the parties. . "Laws" shall mean all federal, state and local laws and regulations that apply to this Agreement including, without limitation, (i) the Bayh-Dole Act (ii) the TM TM TM Federal Food, Drug, and Cosmetic Act ( U.S.C Â§ et seq.) (iii) the federal Anti-kickback Statute ( U.S.C. Â§ a- b(b)) (iv) the Stark Law ( U.S.C. Â§ nn) (v) the Anti-Inducement Law ( U.S.C. Â§ a- a(a)( )) (vi) the civil False Claims Act ( U.S.C. Â§Â§ et seq.) (vii) the administrative False Claims Law ( U.S.C. Â§ a- b(a)) (viii) the Health Insurance Portability and Accountability Act of ( U.S.C. Â§ d et seq.), (ix) the exclusion laws (x) SSA Â§ ( U.S.C. Â§ a- ) (xi) Medicare (Title XVIII of the Social Security Act), (xii) Medicaid (Title XIX of the Social Security Act); (xiii) the Clinical Laboratory Improvements Act of (CLIA); and (xiv) data security, protection and privacy laws in the applicable jurisdictions. . "Professional Component" shall mean the <EVENT class="COREFERENCE" eid="e39">performance</EVENT> of the professional component of the steps of the Assay, which is the <EVENT class="COREFERENCE" eid="e40">interpretation</EVENT> of results (generated in the Technical Component) of an Assay by a pathologist, and is covered by CPT codes from the Professional Fee Schedule with the modifier " ". . "Technical Component" shall mean the <EVENT class="COREFERENCE" eid="e41">performance</EVENT> of the technical component of the steps of the Assay, which is the physical <EVENT class="COREFERENCE" eid="e42">performance</EVENT> of the Assay procedure up to the <EVENT class="COREFERENCE" eid="e43">interpretation</EVENT> of results, and is covered by CPT codes from the Professional Fee Schedule without the modifier " ", and typically with a modifier "TC". . " Term " shall have the meaning provided in Section . . . "Test(s)" shall mean the Assay, which is a laboratory developed test, and/or any Collaboration Assay which is added to this Agreement pursuant to Section . (e), performed as a clinical reference laboratory test. . "Territory" shall mean the United States of America, and other countries of the world, contingent in the latter case on the parties agreeing in writing on an appropriate strategy to access them in accordance with Section . . . "Third Party(ies)" shall mean any entity other than Biocept or Life Technologies or an Affiliate of Biocept or Life Technologies. . APPOINTMENT; LICENSES . Appointment. Upon the terms and conditions set forth in this Agreement, Biocept hereby <EVENT class="COREFERENCE" eid="e44">grants</EVENT> Life Technologies during the Term the non-exclusive right, as further <EVENT class="COREFERENCE" eid="e45">defined</EVENT> in Section . , to <EVENT class="COREFERENCE" eid="e46">promote</EVENT> the Tests in the Territory and to <EVENT class="COREFERENCE" eid="e47">perform</EVENT> the Professional Component of the Tests <EVENT class="COREFERENCE" eid="e48">sold</EVENT> by the parties in the Territory, in accordance with the terms of this Agreement. . Trademark Licenses. The parties hereby <EVENT class="COREFERENCE" eid="e49">grant</EVENT> to each other non-exclusive, fully- <EVENT class="COREFERENCE" eid="e50">paid</EVENT> , royalty-free licenses to <EVENT class="COREFERENCE" eid="e51">utilize</EVENT> the other party's trademarks, as follows : (a) Biocept Trademarks. To <EVENT class="COREFERENCE" eid="e52">facilitate</EVENT> the <EVENT class="COREFERENCE" eid="e53">promotion</EVENT> and <EVENT class="COREFERENCE" eid="e54">performance</EVENT> of Tests, during the Term Biocept hereby <EVENT class="COREFERENCE" eid="e55">grants</EVENT> Life Technologies a non-exclusive, royalty-free, non-transferable license to <EVENT class="COREFERENCE" eid="e56">use</EVENT> the Biocept Trademarks solely for use in connection with the <EVENT class="COREFERENCE" eid="e57">promotion</EVENT> and <EVENT class="COREFERENCE" eid="e58">performance</EVENT> of the Tests in the Territory. All materials <EVENT class="COREFERENCE" eid="e59">associated</EVENT> with the Tests and <EVENT class="COREFERENCE" eid="e60">used</EVENT> by Life Technologies in connection with the <EVENT class="COREFERENCE" eid="e61">promotion</EVENT> of the Tests, including web- based , shall be <EVENT class="COREFERENCE" eid="e62">co</EVENT> - branded with such Biocept Trademarks as <EVENT class="COREFERENCE" eid="e63">approved</EVENT> by Biocept prior to <EVENT class="COREFERENCE" eid="e64">distribution</EVENT> All <EVENT class="COREFERENCE" eid="e65">use</EVENT> of Biocept Trademarks by Life Technologies hereunder ( including all goodwill arising as a result of such use) shall <EVENT class="COREFERENCE" eid="e66">inure</EVENT> to the benefit of Biocept, and these rights, whether registered or not <EVENT class="COREFERENCE" eid="e67">registered</EVENT> , at all times shall <EVENT class="COREFERENCE" eid="e68">remain</EVENT> the sole property of Biocept. <EVENT class="COREFERENCE" eid="e69">Biocept</EVENT> shall <EVENT class="COREFERENCE" eid="e70">provide</EVENT> Life Technologies with copies of the Biocept Trademarks in an appropriate form for the uses <EVENT class="COREFERENCE" eid="e71">contemplated</EVENT> in this Agreement. Life Technologies shall <EVENT class="COREFERENCE" eid="e72">provide</EVENT> Biocept with samples of all <EVENT class="COREFERENCE" eid="e73">proposed</EVENT> use of the Biocept Trademarks in advance of such <EVENT class="COREFERENCE" eid="e74">proposed</EVENT> use and Biocept shall have the right to <EVENT class="COREFERENCE" eid="e75">approve</EVENT> the appearance and <EVENT class="COREFERENCE" eid="e76">placement</EVENT> of Biocept Trademarks by Life Technologies for the purpose of protecting and maintaining the standards of quality <EVENT class="COREFERENCE" eid="e77">maintained</EVENT> by Biocept for products <EVENT class="COREFERENCE" eid="e78">sold</EVENT> under the Biocept Trademarks and for use of the Biocept Trademarks. If Biocept at any time <EVENT class="COREFERENCE" eid="e79">finds</EVENT> that Life Technologies is not in compliance with this Section, then Biocept may <EVENT class="COREFERENCE" eid="e80">notify</EVENT> Life Technologies in writing of such <EVENT class="COREFERENCE" eid="e81">deficiencies</EVENT> and if Life Technologies <EVENT class="COREFERENCE" eid="e82">fails</EVENT> to <EVENT class="COREFERENCE" eid="e83">correct</EVENT> such <EVENT class="COREFERENCE" eid="e84">deficiencies</EVENT> within thirty ( ) days after <EVENT class="COREFERENCE" eid="e85">receipt</EVENT> of such notice, Biocept may, at its <EVENT class="COREFERENCE" eid="e86">election</EVENT> and in addition to any other remedies, <EVENT class="COREFERENCE" eid="e87">terminate</EVENT> the license <EVENT class="COREFERENCE" eid="e88">granted</EVENT> to Life Technologies with respect to the Biocept Trademarks. Life Technologies shall <EVENT class="COREFERENCE" eid="e89">display</EVENT> the â¢ or symbol, as <EVENT class="COREFERENCE" eid="e90">directed</EVENT> by Biocept, in connection with Life Technologies' use of the Biocept Trademarks. (b) Life Technologies Trademarks. To <EVENT class="COREFERENCE" eid="e91">facilitate</EVENT> the <EVENT class="COREFERENCE" eid="e92">promotion</EVENT> and <EVENT class="COREFERENCE" eid="e93">performance</EVENT> of Tests, during the Term Life Technologies hereby <EVENT class="COREFERENCE" eid="e94">grants</EVENT> Biocept a non-exclusive, royalty-free, non-transferable license to <EVENT class="COREFERENCE" eid="e95">use</EVENT> the Life Technologies Trademarks solely for use in connection with the <EVENT class="COREFERENCE" eid="e96">promotion</EVENT> and <EVENT class="COREFERENCE" eid="e97">performance</EVENT> of the Tests in the Territory. Materials <EVENT class="COREFERENCE" eid="e98">associated</EVENT> with the Tests and <EVENT class="COREFERENCE" eid="e99">used</EVENT> by Biocept in connection with the <EVENT class="COREFERENCE" eid="e100">promotion</EVENT> of Tests, including web- based materials, may be <EVENT class="COREFERENCE" eid="e101">co</EVENT> - branded with such Life Technologies Trademarks as <EVENT class="COREFERENCE" eid="e102">approved</EVENT> by the parties prior to <EVENT class="COREFERENCE" eid="e103">distribution</EVENT> All <EVENT class="COREFERENCE" eid="e104">use</EVENT> of Life Technologies Trademarks by Biocept hereunder including all goodwill arising as a result of such use) shall <EVENT class="COREFERENCE" eid="e105">inure</EVENT> to the benefit of Life Technologies, and these rights, whether registered or not <EVENT class="COREFERENCE" eid="e106">registered</EVENT> , at all times shall <EVENT class="COREFERENCE" eid="e107">remain</EVENT> the sole property of Life Technologies. Life Technologies shall <EVENT class="COREFERENCE" eid="e108">provide</EVENT> Biocept with copies of the Life Technologies Trademarks in an appropriate form for the uses <EVENT class="COREFERENCE" eid="e109">contemplated</EVENT> in this Agreement. Biocept shall <EVENT class="COREFERENCE" eid="e110">provide</EVENT> Life Technologies with samples of all <EVENT class="COREFERENCE" eid="e111">proposed</EVENT> use of the Life Technologies Trademarks in advance of such <EVENT class="COREFERENCE" eid="e112">proposed</EVENT> use and Life Technologies shall have the right to <EVENT class="COREFERENCE" eid="e113">approve</EVENT> the appearance and <EVENT class="COREFERENCE" eid="e114">placement</EVENT> of Life Technologies Trademarks by Biocept for the purpose of protecting and maintaining the standards of quality <EVENT class="COREFERENCE" eid="e115">maintained</EVENT> by Life Technologies for products <EVENT class="COREFERENCE" eid="e116">sold</EVENT> under the Life Technologies Trademarks and for use of the Life Technologies Trademarks. If Life Technologies at any time <EVENT class="COREFERENCE" eid="e117">finds</EVENT> that Biocept is not in compliance with this Section, then Life Technologies may <EVENT class="COREFERENCE" eid="e118">notify</EVENT> Biocept in writing of such <EVENT class="COREFERENCE" eid="e119">deficiencies</EVENT> and if Biocept <EVENT class="COREFERENCE" eid="e120">fails</EVENT> to <EVENT class="COREFERENCE" eid="e121">correct</EVENT> such <EVENT class="COREFERENCE" eid="e122">deficiencies</EVENT> within thirty ( ) days after <EVENT class="COREFERENCE" eid="e123">receipt</EVENT> of such notice, Life Technologies may, at its <EVENT class="COREFERENCE" eid="e124">election</EVENT> and in addition to any other remedies, <EVENT class="COREFERENCE" eid="e125">terminate</EVENT> the license <EVENT class="COREFERENCE" eid="e126">granted</EVENT> to Biocept with respect to the Life Technologies Trademarks. Biocept shall <EVENT class="COREFERENCE" eid="e127">display</EVENT> the â¢ or symbol, as <EVENT class="COREFERENCE" eid="e128">directed</EVENT> by Life Technologies, in connection with Biocept's <EVENT class="COREFERENCE" eid="e129">use</EVENT> of the Life Technologies Trademarks. Â® Â® . Exclusivity. During the Term , the parties will <EVENT class="COREFERENCE" eid="e130">promote</EVENT> and <EVENT class="COREFERENCE" eid="e131">perform</EVENT> Tests for the clinical testing market on a non- exclusive basis in the Territory, except as otherwise <EVENT class="COREFERENCE" eid="e132">provided</EVENT> for below. Biocept will have sole responsibility for performing the Technical Component of all Tests <EVENT class="COREFERENCE" eid="e133">sold</EVENT> by the parties, until and unless Life Technologies <EVENT class="COREFERENCE" eid="e134">obtains</EVENT> the right from Biocept to independently <EVENT class="COREFERENCE" eid="e135">develop</EVENT> its own Tests in accordance with all applicable FDA regulatory requirements, as <EVENT class="COREFERENCE" eid="e136">provided</EVENT> for in Section . . Life Technologies will be <EVENT class="COREFERENCE" eid="e137">authorized</EVENT> to <EVENT class="COREFERENCE" eid="e138">perform</EVENT> the Professional Component of all Tests <EVENT class="COREFERENCE" eid="e139">sold</EVENT> by the parties, although Biocept may <EVENT class="COREFERENCE" eid="e140">engage</EVENT> other groups in promotion, marketing and performance arrangements for the Tests, at the discretion of Biocept. Biocept shall <EVENT class="COREFERENCE" eid="e141">provide</EVENT> thirty ( ) days written notice to Life Technologies before <EVENT class="COREFERENCE" eid="e142">entering</EVENT> into any such promotion, marketing and performance arrangement. . COLLABORATION . Purpose. During the Term , the parties <EVENT class="COREFERENCE" eid="e143">agree</EVENT> to <EVENT class="COREFERENCE" eid="e144">cooperate</EVENT> and <EVENT class="COREFERENCE" eid="e145">collaborate</EVENT> to <EVENT class="COREFERENCE" eid="e146">develop</EVENT> , <EVENT class="COREFERENCE" eid="e147">promote</EVENT> and <EVENT class="COREFERENCE" eid="e148">commercialize</EVENT> the Tests for the clinical testing market in the Territory and in accordance with the terms of this Agreement (the "Collaboration"). The principal objective of the parties hereunder is to <EVENT class="COREFERENCE" eid="e149">maximize</EVENT> the <EVENT class="COREFERENCE" eid="e150">commercialization</EVENT> of the Tests in the Territory. The parties shall <EVENT class="COREFERENCE" eid="e151">deploy</EVENT> each of their respective sales forces in accordance with the terms of this Agreement in an effort to <EVENT class="COREFERENCE" eid="e152">promote</EVENT> the Tests in the Territory in the manner as <EVENT class="COREFERENCE" eid="e153">agreed</EVENT> to by the parties, under the direction of the Joint Steering Committee. . Commercialization of Tests Outside the USA. At any time for up to two ( ) years after the Effective Date , should Life Technologies desire to <EVENT class="COREFERENCE" eid="e154">offer</EVENT> for sale any Test outside the USA, it shall first <EVENT class="COREFERENCE" eid="e155">discuss</EVENT> with Biocept an appropriate strategy and plan for such <EVENT class="COREFERENCE" eid="e156">effort</EVENT> Such strategy and plan may <EVENT class="COREFERENCE" eid="e157">involve</EVENT> the <EVENT class="COREFERENCE" eid="e158">development</EVENT> of, and obtaining all applicable regulatory authorizations for, an in vitro diagnostic kit, instruments or similar systems, in collaboration with Biocept (with funding support, and more fully <EVENT class="COREFERENCE" eid="e159">described</EVENT> in Section . ), such strategy and plan to be <EVENT class="COREFERENCE" eid="e160">reduced</EVENT> to writing and <EVENT class="COREFERENCE" eid="e161">approved</EVENT> by the parties. If such <EVENT class="COREFERENCE" eid="e162">written</EVENT> plan is not <EVENT class="COREFERENCE" eid="e163">approved</EVENT> by the parties within two ( ) years of the Effective Date , the Territory shall <EVENT class="COREFERENCE" eid="e164">revert</EVENT> to only the USA, unless otherwise <EVENT class="COREFERENCE" eid="e165">agreed</EVENT> to by the parties. . Life Technologies Responsibilities. Life Technologies shall <EVENT class="COREFERENCE" eid="e166">use</EVENT> commercially reasonable <EVENT class="COREFERENCE" eid="e167">efforts</EVENT> to <EVENT class="COREFERENCE" eid="e168">promote</EVENT> the Tests in the Territory, in accordance with Section . , using sales channels and methods, and adhering to substantially similar standards that it generally <EVENT class="COREFERENCE" eid="e169">employs</EVENT> with respect to its laboratory <EVENT class="COREFERENCE" eid="e170">developed</EVENT> tests. Without limiting the foregoing, Life Technologies' responsibilities with respect to <EVENT class="COREFERENCE" eid="e171">marketing</EVENT> and <EVENT class="COREFERENCE" eid="e172">promotion</EVENT> of the Tests in the Territory during the Term shall <EVENT class="COREFERENCE" eid="e173">include</EVENT> the following : (a) Life Technologies Customers. Life Technologies shall <EVENT class="COREFERENCE" eid="e174">use</EVENT> commercially reasonable <EVENT class="COREFERENCE" eid="e175">efforts</EVENT> to <EVENT class="COREFERENCE" eid="e176">promote</EVENT> the Tests to the appropriate healthcare professionals. (b) Test Performance. Life Technologies shall have the responsibility, subject to its capacity to <EVENT class="COREFERENCE" eid="e177">support</EVENT> in its reasonable discretion (of which capacity Life Technologies shall <EVENT class="COREFERENCE" eid="e178">notify</EVENT> Biocept in <EVENT class="COREFERENCE" eid="e179">writing</EVENT> at least sixty ( ) days before launch of the Assay, and <EVENT class="COREFERENCE" eid="e180">use</EVENT> diligent <EVENT class="COREFERENCE" eid="e181">efforts</EVENT> <EVENT class="COREFERENCE" eid="e182">efforts</EVENT> to <EVENT class="COREFERENCE" eid="e183">notify</EVENT> Biocept at least thirty ( ) days before <EVENT class="COREFERENCE" eid="e184">discovery</EVENT> of any <EVENT class="COREFERENCE" eid="e185">decreases</EVENT> or <EVENT class="COREFERENCE" eid="e186">increases</EVENT> in such capacity), for performing the Professional Component of the Assays <EVENT class="COREFERENCE" eid="e187">sold</EVENT> by either party in the Territory. In particular, the laboratory director of the Life Technologies CLIA laboratory will be responsible for issuing and signing off on the report. (c) Sales, Marketing and Customer Service. (i) Life Technologies shall, at its sole expense and in accordance with Section . , <EVENT class="COREFERENCE" eid="e188">develop</EVENT> and <EVENT class="COREFERENCE" eid="e189">deliver</EVENT> to customers marketing materials for the Tests. Life Technologies shall <EVENT class="COREFERENCE" eid="e190">use</EVENT> , as appropriate, Biocept's "OncoCEE-LU ", OncoCEEâ¢", "CEE-Enhancedâ¢" and "CEE-Sure" brand and the Biocept corporate name and logo, together with any Life Technologies branding , as part of the marketing materials for the <EVENT class="COREFERENCE" eid="e191">marketing</EVENT> of the Tests and, where appropriate, in its other public <EVENT class="COREFERENCE" eid="e192">presentations</EVENT> and <EVENT class="COREFERENCE" eid="e193">disclosures</EVENT> concerning the Assay or Tests.
</TEXT>
<MAKEINSTANCE aspect="NONE" eiid="ei6021" eventID="e0" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6022" eventID="e1" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6023" eventID="e2" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6024" eventID="e3" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6025" eventID="e4" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6026" eventID="e5" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6027" eventID="e6" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6028" eventID="e7" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6029" eventID="e8" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6030" eventID="e9" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6031" eventID="e10" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6032" eventID="e11" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6033" eventID="e12" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6034" eventID="e13" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6035" eventID="e14" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6036" eventID="e15" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6037" eventID="e16" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6038" eventID="e17" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6039" eventID="e18" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6040" eventID="e19" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6041" eventID="e20" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6042" eventID="e21" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6043" eventID="e22" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6044" eventID="e23" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6045" eventID="e24" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6046" eventID="e25" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6047" eventID="e26" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6048" eventID="e27" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6049" eventID="e28" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6050" eventID="e29" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6051" eventID="e30" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6052" eventID="e31" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6053" eventID="e32" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6054" eventID="e33" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6055" eventID="e34" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6056" eventID="e35" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6057" eventID="e36" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6058" eventID="e37" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6059" eventID="e38" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6060" eventID="e39" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6061" eventID="e40" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6062" eventID="e41" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6063" eventID="e42" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6064" eventID="e43" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6065" eventID="e44" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6066" eventID="e45" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6067" eventID="e46" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6068" eventID="e47" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6069" eventID="e48" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6070" eventID="e49" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6071" eventID="e50" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6072" eventID="e51" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6073" eventID="e52" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6074" eventID="e53" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6075" eventID="e54" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6076" eventID="e55" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6077" eventID="e56" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6078" eventID="e57" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6079" eventID="e58" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6080" eventID="e59" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6081" eventID="e60" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6082" eventID="e61" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6083" eventID="e62" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6084" eventID="e63" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6085" eventID="e64" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6086" eventID="e65" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6087" eventID="e66" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6088" eventID="e67" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6089" eventID="e68" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6090" eventID="e69" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6091" eventID="e70" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6092" eventID="e71" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6093" eventID="e72" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6094" eventID="e73" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6095" eventID="e74" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6096" eventID="e75" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6097" eventID="e76" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6098" eventID="e77" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6099" eventID="e78" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6100" eventID="e79" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6101" eventID="e80" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6102" eventID="e81" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6103" eventID="e82" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6104" eventID="e83" polarity="POS" pos="ADJECTIVE" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6105" eventID="e84" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6106" eventID="e85" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6107" eventID="e86" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6108" eventID="e87" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6109" eventID="e88" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6110" eventID="e89" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6111" eventID="e90" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6112" eventID="e91" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6113" eventID="e92" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6114" eventID="e93" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6115" eventID="e94" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6116" eventID="e95" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6117" eventID="e96" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6118" eventID="e97" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6119" eventID="e98" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6120" eventID="e99" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6121" eventID="e100" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6122" eventID="e101" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6123" eventID="e102" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6124" eventID="e103" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6125" eventID="e104" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6126" eventID="e105" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6127" eventID="e106" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6128" eventID="e107" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6129" eventID="e108" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6130" eventID="e109" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6131" eventID="e110" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6132" eventID="e111" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6133" eventID="e112" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6134" eventID="e113" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6135" eventID="e114" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6136" eventID="e115" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6137" eventID="e116" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6138" eventID="e117" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6139" eventID="e118" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6140" eventID="e119" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6141" eventID="e120" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6142" eventID="e121" polarity="POS" pos="ADJECTIVE" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6143" eventID="e122" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6144" eventID="e123" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6145" eventID="e124" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6146" eventID="e125" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6147" eventID="e126" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6148" eventID="e127" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6149" eventID="e128" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6150" eventID="e129" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6151" eventID="e130" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6152" eventID="e131" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6153" eventID="e132" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6154" eventID="e133" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6155" eventID="e134" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6156" eventID="e135" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6157" eventID="e136" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6158" eventID="e137" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6159" eventID="e138" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6160" eventID="e139" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6161" eventID="e140" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6162" eventID="e141" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6163" eventID="e142" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6164" eventID="e143" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6165" eventID="e144" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6166" eventID="e145" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6167" eventID="e146" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6168" eventID="e147" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6169" eventID="e148" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6170" eventID="e149" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6171" eventID="e150" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6172" eventID="e151" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6173" eventID="e152" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6174" eventID="e153" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6175" eventID="e154" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6176" eventID="e155" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6177" eventID="e156" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6178" eventID="e157" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6179" eventID="e158" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6180" eventID="e159" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6181" eventID="e160" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6182" eventID="e161" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6183" eventID="e162" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6184" eventID="e163" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6185" eventID="e164" polarity="POS" pos="PROPN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6186" eventID="e165" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6187" eventID="e166" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6188" eventID="e167" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6189" eventID="e168" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6190" eventID="e169" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6191" eventID="e170" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6192" eventID="e171" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6193" eventID="e172" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6194" eventID="e173" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6195" eventID="e174" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6196" eventID="e175" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6197" eventID="e176" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6198" eventID="e177" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6199" eventID="e178" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6200" eventID="e179" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6201" eventID="e180" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6202" eventID="e181" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6203" eventID="e182" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6204" eventID="e183" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6205" eventID="e184" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6206" eventID="e185" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6207" eventID="e186" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6208" eventID="e187" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6209" eventID="e188" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6210" eventID="e189" polarity="POS" pos="VERB" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6211" eventID="e190" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6212" eventID="e191" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6213" eventID="e192" polarity="POS" pos="NOUN" tense="NONE" />
<MAKEINSTANCE aspect="NONE" eiid="ei6214" eventID="e193" polarity="POS" pos="NOUN" tense="NONE" />
</TimeML>